ArticleTranslational cancer research2026
Epidemiology and prognostic factors of acute erythroid leukemia.
Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute erythroid leukemia (AEL) is a rare, highly aggressive subtype of acute myeloid leukemia (AML) characterized by a propensity for early progression and recurrence and is associated with an unfavorable overall prognosis. However, the epidemiological characteristics and risk factors associated with AEL remain poorly understood. In this study, we aimed to examine the epidemiology, clinical characteristics, and survival trends associated with AEL. Methods: We conducted a retrospective analysis of AEL data from the Surveillance, Epidemiology, and End Results (SEER) database (2000-2021) to examine incidence across age groups. Kaplan-Meier survival analysis was used to determine overall survival (OS) and cancer-specific survival (CSS) rates. Logistic regression was used to identify risk factors associated with early mortality, while univariate and multivariate Cox regression analyses were used to identify prognostic factors. Results: Among 919 patients, the annual incidence rate of AEL showed a declining trend, with higher incidence observed in males than in females. The 60-69-year age group had the highest incidence rate compared to other age groups. Multivariate logistic regression identified the year of diagnosis, age, and chemotherapy as significant risk factors for early mortality. Multivariate Cox proportional hazards analysis also revealed that year of diagnosis, age, and chemotherapy were associated with poor prognosis in patients with AEL. Conclusions: Although the incidence of AEL has decreased, survival outcomes have not improved significantly. Early detection and more aggressive treatment strategies are necessary to address the poor outcomes associated with AEL.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.